Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Daegu
Clinical trial register · South Korea

Clinical Trials in Daegu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3409 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
3409
Studies in scope
all four open statuses
1874
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Seoul 2866 Daegu 553 Seongnam-si 485 Busan 470 Goyang-si 399

Trials with a site in Daegu

553 of 3409 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Boehringer Ingelheim
Phase 3
1,500
Anyang, Cheongju-si, Daegu, Dong-gu Ulsan, Incheon, Seoul, Wŏnju
2027-01-11
Not yet open
Novo Nordisk A/S
Phase 3
400
Seoungnam-si, Suwon, Yangsan, Daegu, Seoul
2027-01-07
Recruiting
Yeungnam University College of Medicine
Phase 3
50
Daegu
2026-12-24
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Anyang-si, Bucheon-si, Seongnam-si, Yangsan, Busan, Daegu, Daejeon, Seoul
2026-11-11
Not yet open
Yonsei University
Observational
600
Yongin, Daegu, Jeonju
2026-11-09
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Bucheon-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Busan, Daegu, Daejeon
2026-10-26
Recruiting
Hoffmann-La Roche
Phase 3
400
Seongnam-si, Busan, Daegu, Daejeon, Gyeonggi-do, Incheon, Jeollanam-do, Seoul
2026-10-06
Recruiting
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
NCT07570394Chronic Obstructive Pulmonary Disease (COPD), Asthma
AstraZeneca
Observational
600
Chuncheon, Daegu, Goyang-si, Gwangmyeong, Jinju, Seongnam-si, Seoul, Wŏnju
2026-09-17
Recruiting
Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe
NCT07282795Influenza Immunization, Healthy Volunteers
Sanofi
Observational
670
Goyang-si, Gunpo, Busan, Daegu, Incheon, Seoul
2026-09-17
Recruiting
AstraZeneca
Phase 3
950
Busan, Daegu, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul, Yangsan
2026-09-16
Recruiting
Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD
NCT07770867Autism Spectrum Disorder, Social Communication Disorder
Neudive Inc.
Not applicable
156
Daegu, Iksan, Seoul, Yangsan
2026-09-15
Recruiting
Takeda
Phase 3
324
Seoul, Seongnam-si, Daegu
2026-09-10
Not yet open
LucasBio
Phase 1/2
42
Seoul, Daegu, Goyang-si, Hwasun, Ulsan
2026-09-01
Recruiting
Keimyung University Dongsan Medical Center
Observational
59
Daegu
2026-09-01
Not yet open
Emotion Regulation Program for Substance Use Disorders
NCT07698821Substance Use Disorder (SUD)
The Catholic University of Korea
Not applicable
20
Daegu, Incheon
2026-09
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongbuk-Gu, Seoul
2026-08-24
Not yet open
Seoul National University Hospital
Not applicable
3,000
Seongnam-si, Uijeongbu-si, Daegu, Seoul
2026-08-24
Recruiting
Chonnam National University Hospital
Not applicable
1,252
Bucheon-si, Changwon, Cheonan, Cheongju-si, Chuncheon, Daegu, Daejeon, Gwangju
2026-08-21
Recruiting
Keimyung University Dongsan Medical Center
Not applicable
150
Daegu
2026-08-21
Recruiting
AstraZeneca
Phase 3
1,500
Busan, Daegu, Daejeon, Incheon, Seoul, Suwon
2026-08-20
Recruiting
AstraZeneca
Phase 3
2,500
Anyang, Bucheon-si, Daegu, Seoul, Yangsan
2026-08-19
Recruiting
Keimyung University Dongsan Medical Center
Observational
20
Daegu
2026-08-13
Recruiting
The Prediction of Clinical Outcome Using the Serum BDNF Level
NCT07776379Chronic Low Back Pain, Brain Derived Neurotrophic Factor Level
Keimyung University Dongsan Medical Center
Observational
70
Daegu
2026-08-13
Recruiting
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
NCT07631156Heart Failure With Reduced Ejection Fraction, Heart Failure, Ventricular Dysfunction, Left
Kyungsub Song
Phase 4
80
Daegu, Seongnam-si, Suwon, Yangsan, Seoul
2026-08-12
Recruiting
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
NCT07746895C3 Glomerulopathy (C3G), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Swedish Orphan Biovitrum
Phase 4
150
Daegu, Daejeon, Seongnam, Seoul
2026-08-05
Not yet open
Craving Management Program for Substance Use Disorders
NCT07698808Substance Use Disorder (SUD)
The Catholic University of Korea
Not applicable
20
Daegu, Incheon
2026-08
Not yet open
Seoul National University Hospital
Not applicable
1,724
Ansan, Anyang, Busan, Changwon, Cheonan, Daegu, Gwangju, Incheon
2026-07-29
Recruiting
AstraZeneca
Phase 3
1,200
Busan, Changwon-si, Daegu, Daejeon, Guri-si, Incheon, Seoul
2026-07-06
Recruiting
SK Bioscience Co., Ltd.
Phase 3
780
Daegu, Ansan, Hwaseong-si, Seongnam-si, Incheon, Seoul
2026-07-04
Recruiting
Sanofi
Observational
706
Busan, Daegu, Goyang, Gwangju, Hanam, Iksan, Seongnam, Seoul
2026-07-01
Recruiting
AstraZeneca
Phase 3
4,500
Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Jongno-gu, Seoul, Suwon
2026-06-29
Recruiting
The Effect of NSAID on Serum Periostin
NCT07662668Intervertebral Disc Disease
Keimyung University Dongsan Medical Center
Observational
144
Daegu
2026-06-22
Recruiting
Relationship of Periostin and ODI, EQ-5D
NCT07664904Intervertebral Disc Disease
Keimyung University Dongsan Medical Center
Observational
53
Daegu
2026-06-22
Not yet open
First Step Program for Substance Use Disorders
NCT07658963Substance Use Disorder (SUD)
The Catholic University of Korea
Not applicable
20
Daegu, Incheon
2026-06-22
Recruiting
Yonsei University
Not applicable
748
Yongin-si, Daegu, Jeonju
2026-06-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Goyang-si, Suwon, Cheongju-si, Daegu, Seoul
2026-06-18
Recruiting
AstraZeneca
Phase 3
150
Cheonan-si, Daegu, Goyang-si, Hwasun-eup, Incheon, Seongbuk-Gu, Seongnam-si, Seoul
2026-06-15
Not yet open
Seoul National University Hospital
Not applicable
2,301
Chuncheon, Gangneung, Anyang-si, Bucheon-si, Goyang-si, Changwon, Busan, Daegu
2026-06-15
Recruiting
Eikon Therapeutics
Phase 2/3
750
Daegu, Seoul, Incheon, Hwasun
2026-06-15
Recruiting
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
NCT07646678Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2
Takeda
Phase 2/3
500
Daegu
2026-06-11
By invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Wŏnju, Busan, Daegu, Daejeon, Seoul
2026-06-08
Recruiting
GlaxoSmithKline
Phase 3
600
Cheongju Chungcheongbuk-do, Daegu, Seongnam-si Gyeonggi-do, Seoul
2026-06-04
Recruiting
Samsung Medical Center
Observational
396
Daegu, Daejeon, Seongnam-si, Yangsan, Incheon, Jeju City, Jeonju, Hwasun
2026-05-28
Recruiting
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
NCT07572032Heart Failure Due to Coronary Artery Disease, Valvular Cardiomyopathy, Heart Failure
Kyungsub Song
Phase 4
80
Daegu, Seongnam-si, Suwon, Seoul
2026-05-20
Recruiting
Transition of Care in Pediatric Rare Endocrine Disorders
NCT07786142Endocrine Disorder, Rare Disorders
Seoul National University Hospital
Not applicable
150
Daegu, Daejeon, Gwangju, Hwasun, Incheon, Jeonju, Seongnam, Seoul
2026-05-20
Recruiting
A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome
NCT07285005Venous Malformations, Lymphatic Malformations, Klippel-Trenaunay Syndrome, CLOVES Syndrome
Kaken Pharmaceutical
Phase 3
150
Daegu, Seoul
2026-05-13
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Daegu, Wŏnju, Bundang Gu, Suwon, Incheon, Seoul, Busan, Gwangju
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Wŏnju, Anyang-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Daegu, Daejeon
2026-05-11
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
390
Daegu, Seongnam-si, Seoul
2026-05-11
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Goyang-si, Seongnam-si, Daegu, Seoul
2026-05-06
By invitation
Ho-Won Lee
Not applicable
50
Daegu
2026-05-04
Not yet open
Addpharma Inc.
Phase 1
24
Daegu
2026-05
Not yet open
Prospective International Multi-center Clinical Trial of PGT-A Upgrade
NCT07533630Infertility Assisted Reproductive Technology
Reproductive & Genetic Hospital of CITIC-Xiangya
Observational
1,700
Daegu
2026-05
Recruiting
Hoffmann-La Roche
Phase 3
360
Daegu
2026-04-27
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Daegu, Goyang-si, Seoul
2026-04-17
Active, closed
Aribio Lab Co., Ltd.
Phase 2
135
Daegu, Seongnam-si, Yongin, Jeonju, Seoul
2026-04-17
Recruiting
LEXURE for Post-Stroke Aphasia
NCT07570264Aphasia
Nunaps Inc
Not applicable
116
Ansan, Busan, Chuncheon, Daegu, Gwangju, Ilsan, Jeonju, Seoul
2026-04-16
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
Novartis Pharmaceuticals
Phase 3
650
Daegu, Ansan, Hwaseong-si, Suwon, Dongjak Gu, Seoul, Gwangju, Incheon
2026-04-16
Recruiting
Eisai Co., Ltd.
Phase 2
256
Daegu, Gwangju
2026-03-31
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Busan, Daegu, Daejeon, Gwangju, Gyeongsan-si, Pusan, Seoul, Wŏnju
2026-03-26
Recruiting
Yuhan Corporation
Phase 2
150
Gyeonggi-do, Daegu, Seoul, Yangsan, Incheon
2026-03-26
Recruiting
Eisai Inc.
Phase 2
64
Seongnam-si, Daegu, Seoul, Suwon
2026-03-26
Recruiting
Samsung Medical Center
Not applicable
2,100
Seoul, Busan, Changwon, Daegu, Gwangju, Gwangmyeong, Gyeonggi-do, Iksan
2026-03-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Goyang-si, Suwon, Daegu, Seoul
2026-03-18
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Daegu, Seongnam-si, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seoul
2026-03-16
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.
Phase 3
900
Daegu, Busan, Seoul
2026-03-09
Recruiting
Yeungnam University College of Medicine
Phase 3
50
Daegu
2026-03-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Seodaemun-Gu, Daegu, Seoul
2026-02-16
Recruiting
Hanmi Pharmaceutical Company Limited
Phase 2
45
Seongnam-si, Hwasun, Busan, Daegu, Daejeon, Seoul
2026-02-12
Recruiting
ViiV Healthcare
Phase 2
186
Daegu, Gwangju, Pusan, Seoul
2026-02-11
Recruiting
Eli Lilly and Company
Phase 3
900
Daegu, Dongjak-gu, Seoul, Uijeongbu-si
2026-02-09
Recruiting
AstraZeneca
Phase 3
2,130
Daegu, Hwasun-gun, Seongnam-si, Seoul
2026-02-03
Recruiting
Genmab
Phase 2
240
Cheongju-si, Daegu, Incheon, Seoul, Suwon
2026-01-30
By invitation
Immunovant Sciences GmbH
Phase 2
372
Daegu, Gyeonggi-do
2026-01-26
Recruiting
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
NCT07687706Ischemic Stroke, Ischemic Stroke, Acute, Transient Ischemic Attack (TIA), Cerebrovascular Disease
Hanyang University Guri Hospital
Phase 3
1,524
Busan, Daegu, Chuncheon, Anyang-si, Iksan, Jeonju, Cheongju-si, Guri-si
2026-01-26
Recruiting
Sanofi
Phase 3
751
Ansan-si, Busan, Daegu, Seoul, Suwon
2026-01-16
Recruiting
ROKIT Healthcare
Phase 4
104
Daegu, Bucheon-si, Guri-si, Gwangmyeong, Seongnam-si, Goyang, Incheon, Jeonju
2025-12-29
Recruiting
AstraZeneca
Phase 3
1,100
Busan, Daegu, Goyang-si, Seongnam-si, Seoul, Suwon, Yangsan
2025-12-29
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Daegu, Seongnam-si, Suwon, Cheongju-si, Goyang-si, Pusan, Yangsan, Jinju
2025-12-22
By invitation
The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer
NCT07376980Rectal Neoplasms, Rectal Neoplasms Malignant, Rectal Cancer, Rectal Cancer Surgery
Korea University Anam Hospital
Not applicable
450
Suwon, Daegu, Seoul
2025-12-20
Recruiting
Incyte Corporation
Phase 3
466
Ansan-si, Changwon-si, Daegu, Goyang-si, Seongnam-si, Seoul
2025-12-09
Active, closed
Boehringer Ingelheim
Phase 3
135
Daegu, Gwangju, Seongnam, Seoul
2025-12-09
Recruiting
AstraZeneca
Phase 3
1,100
Busan, Daegu, Seongnam-si, Seoul
2025-12-04
Recruiting
GlaxoSmithKline
Phase 3
450
Seoul, Daegu, Seongnam-si Gyeonggi-do, Suwon Kyunggi-do, Yangsan
2025-12-03
Recruiting
Eli Lilly and Company
Phase 3
7,140
Busan, Daegu, Guri-si, Gwangju, Namdong-gu, Seongnam, Seoul, Ulsan
2025-12-01
Not yet open
Extra-Peritoneal Tunneling Versus Conventional Drain Fixation After Anterior or Low Anterior Resection
NCT07241143Rectal Diseases, Sigmoid Colon Disease, Rectal Cancer, Sigmoid Colon Cancer
Yeungnam University Hospital
Not applicable
596
Daegu
2025-12-01
Recruiting
Hoffmann-La Roche
Phase 3
250
Daegu, Gyeonggi-do, Seoul
2025-11-27
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Busan, Daegu, Goyang-si, Seoul
2025-11-25
Recruiting
Gachon University Gil Medical Center
Phase 4
64
Busan, Chungju, Daegu, Daejeon, Gwangju, Incheon, Seoul, Wŏnju
2025-11-24
Recruiting
Tau-MEDICAL Co., Ltd.
Not applicable
20
Daegu, Yangsan, Seoul
2025-11-20
By invitation
Novo Nordisk A/S
Observational
500
Goyang-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Busan, Daegu, Daejeon
2025-11-10
Recruiting
AstraZeneca
Phase 2
435
Anyang-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Ulsan
2025-11-06
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Oncology, Inc.
Phase 3
1,000
Busan, Daegu, Goyang-si, Seongnam-si, Suwon, Yongin-si, Seoul
2025-11-03
Recruiting
Eli Lilly and Company
Phase 3
1,205
Daegu, Seoul
2025-10-31
Recruiting
Takeda
Phase 3
70
Daegu, Seoul
2025-10-27
Recruiting
Keimyung University Dongsan Medical Center
Observational
100
Daegu
2025-10-23
Recruiting
Eli Lilly and Company
Phase 3
1,630
Daegu, Goyang-si, Seongnam, Seoul, Suwon
2025-10-22
Recruiting
Neudive Inc.
Not applicable
48
Daegu, Seoul
2025-10-16
Recruiting
Eli Lilly and Company
Phase 3
4,500
Ansan-si, Bucheon-si, Busan, Daegu, Dongjak-gu, Guri-si, Incheon, Jinju
2025-10-15
Recruiting
Pfizer
Phase 2/3
982
Incheon, Seongnam, Seongnam-si, Seoul, Daegu, Busan
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Busan, Daegu, Daejeon, Dongdaemun-gu, Seongnam-si, Seoul, Suwon
2025-10-03
Recruiting
Samsung Medical Center
Not applicable
3,500
Bucheon-si, Daegu, Gwangju, Gwangmyeong, Ilsan, Incheon, Jeonju, Jinju
2025-10-02
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Busan, Daegu, Daejeon, Seoul, Suwon
2025-10-01
Recruiting
Sanofi
Phase 3
980
Ansan-si, Busan, Daegu, Daejeon, Gwangju, Seoul, Suwon
2025-10-01
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Daejeon, Daegu, Busan-si, Pusan, Ulsan, Namdong, Hwasun, Seoul
2025-09-26
Recruiting
STarting incrEmental Prescription of Peritoneal Dialysis
NCT06642597Peritoneal Dialysis (PD), Kidney Failure
The University of Queensland
Not applicable
224
Chuncheon, Daegu
2025-09-19
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Anyang-si, Busan, Changwon-si, Cheongju-si, Daegu, Daejeon, Goyang-si, Gwangju
2025-09-06
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Daegu, Gwangju, Namdong-gu, Seongnam, Seoul, Suwon, Ulsan
2025-09-02
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
NCT06989359IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN)
ADARx Pharmaceuticals, Inc.
Phase 2
45
Wŏnju, Gyeonggi-do, Seoul, Cheonan, Daegu
2025-08-28
Recruiting
Seoul National University Bundang Hospital
Phase 2
130
Busan, Daegu, Gangneung, Seongnam-si, Incheon, Hwasun, Cheongju-si, Seoul
2025-08-27
Recruiting
Bilix Co.,Ltd.
Phase 2
50
Daegu, Seongnam, Seoul, Yangsan
2025-08-26
Recruiting
Pfizer
Phase 3
6,000
Chuncheon, Gwangju, Seoul, Daegu
2025-08-25
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc.
Phase 2
218
Daegu, Gwangju, Seoul
2025-08-19
Recruiting
Chonnam National University Hospital
Not applicable
256
Busan, Daegu, Gwangju, Jeonju, Seoul, Ulsan
2025-08-18
Recruiting
MapLight Therapeutics
Phase 2
300
Daegu, Incheon
2025-08-15
Recruiting
Takeda
Phase 3
150
Seongnam-si, Daegu, Seoul
2025-08-14
Recruiting
GlaxoSmithKline
Phase 3
420
Changwon, Cheongju Chungcheongbuk-do, Daegu, Gyeonggi-do, Seongnam-si Gyeonggi-do, Seoul, Suwon Gyeonggi-do, Ulsan
2025-08-11
Recruiting
AstraZeneca
Phase 3
700
Busan, Daegu, Goyang-si, Seongnam-si, Seoul
2025-08-06
Recruiting
Myungmoon Pharma. Co. Ltd.
Phase 4
484
Ansan, Bucheon-si, Suwon, Busan, Daegu, Gyeonggi-do, Incheon, Seoul
2025-07-28
Active, closed
Amgen
Phase 3
12,800
Daegu, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Gyeonggi-do, Seoul, Ulsan, Wonju-si, Gangwon-do
2025-07-25
Recruiting
Jung-min Ahn
Phase 4
5,000
Anyang, Bucheon-si, Busan, Changwon, Cheonju, Chuncheon, Daegu, Daejeon
2025-07-24
Recruiting
Pusan National University Yangsan Hospital
Phase 2
186
Daegu, Daejeon, Goyang, Hwasun, Incheon, Jeonju, Seongnam, Seoul
2025-07-23
Recruiting
4D Molecular Therapeutics
Phase 3
480
Seogu, Seoul, Seongnam-si, Daegu
2025-07-22
Recruiting
Daiichi Sankyo
Phase 2
130
Busan, Daegu, Goyang-si, Incheon, Jeonju, Seongnam, Seoul, Suwon
2025-07-18
Active, closed
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033Primary Myelofibrosis, Myeloproliferative Neoplasm
PharmaEssentia
Phase 3
160
Daegu, Seongnam-si, Hwasun, Seocho, Seoul
2025-07-18
Recruiting
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT07002164Myocardial Infarction (MI), Heart Failure
Chonnam National University Hospital
Not applicable
780
Changwon, Daegu, Daejeon, Gwangju, Jeonju, Jinju, Pusan, Seongnam
2025-07-15
Recruiting
Asan Medical Center
Phase 4
2,340
Seoul, Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon
2025-07-10
Recruiting
Novo Nordisk A/S
Phase 2
200
Cheongju-si, Daegu, Gangwon-do, Seongnam-si, Gyeonggi-do, Seoul
2025-06-30
Recruiting
Novo Nordisk A/S
Phase 2
200
Cheongju-si, Daegu, Gangwon-do, Seongnam-si, Gyeonggi-do, Seoul
2025-06-27
Recruiting
AstraZeneca
Phase 2
987
Anyang-si, Cheongju-si, Chuncheon, Daegu, Jeonju, Seongnam-si, Seoul, Wŏnju
2025-06-27
Recruiting
GlaxoSmithKline
Phase 3
961
Daegu, Incheon, Jeonju, Seoul
2025-06-23
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Daegu, Goyang, Guri-si, Seoul
2025-06-19
Active, closed
AbbVie
Phase 3
573
Busan, Daegu, Daejeon, Seongnam-si, Suwon, Gwangju, Seoul
2025-06-17
Recruiting
Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy
NCT06984952Enhanced Recovery After Surgery, Gastrectomy for Gastric Cancer
Seoul National University Hospital
Not applicable
308
Busan, Daegu, Daejeon, Goyang, Seongnam, Seoul, Suwon
2025-06-13
Active, closed
Eisai Korea Inc.
Phase 4
94
Busan, Daegu, Daejeon, Gyeonggi-do, Gyeongnam, Jungnam, Seoul
2025-06-11
Recruiting
BioNTech SE
Phase 3
480
Changwon, Daegu, Goyang, Seongnam, Seongnam-si, Seoul
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Anyang, Chungju, Daegu, Dong-gu Ulsan, Incheon, Seoul, Wŏnju
2025-06-09
Recruiting
Calico Life Sciences LLC
Phase 2
240
Busan, Daegu, Seoul
2025-06-09
Recruiting
AstraZeneca
Phase 3
15,100
Bucheon-si, Busan, Changwon-si, Daegu, Daejeon, Goyang-si, Gwangju, Gwangmyeong
2025-06-04
Recruiting
Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms
NCT07079215Opioid Withdrawal (Disorder), Opioid Use Disorder
Nu Eyne Co., Ltd.
Not applicable
24
Daegu
2025-05-30
Recruiting
Boryung Pharmaceutical Co., Ltd
Phase 2
120
Daegu, Guri-si
2025-05-30
Active, closed
AstraZeneca
Phase 3
3,103
Anyang-si, Bucheon-si, Busan, Changwon-si, Cheonan-si, Daegu, Daejeon, Gangwon-do
2025-05-28
Recruiting
Regeneron Pharmaceuticals
Phase 2
397
Gyeonggi-do, Seongnam-si, Incheon, Daegu, Seoul
2025-05-28
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Busan, Daegu, Daejeon, Seoul, Suwon, Wŏnju
2025-05-27
Recruiting
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
NCT06962098Diabetic Kidney Disease (DKD)
Aptabio Therapeutics, Inc.
Phase 2
186
Ansan-si, Busan, Cheonan, Daegu, Goyang-si, Guri-si, Gwangmyeong, Incheon
2025-05-26
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
500
Goyang-si, Seongnam-si, Suwon, Hwasungun, Cheongju-si, Seocho-gu, Daegu, Incheon
2025-05-22
Active, closed
Upstream Bio Inc.
Phase 2
396
Daegu, Jungbuk, Seoul
2025-05-21
Recruiting
Pfizer
Phase 2
252
Jeonju, Daegu, Seoul
2025-05-20
Recruiting
Medipixel XA-Assisted PCI in Coronary Artery Disease
NCT06985693Percutaneous Coronary Intervention (PCI), Coronary Arterial Disease (CAD)
CHA University
Not applicable
830
Gwangmyeong, Seongnam-si, Daegu, Gwangju, Jeonju, Ulsan
2025-05-15
Recruiting
Hoffmann-La Roche
Phase 3
425
Ansan-si, Daegu, Gwangju, Seoul
2025-05-12
Recruiting
Samsung Medical Center
Not applicable
1,200
Ansan, Daegu, Gangneung, Goyang, Gwangju, Gwangmyeong, Incheon, Jeonju
2025-04-07
Recruiting
Pfizer
Phase 3
674
Cheonan-si, Jeonju, Seongnam, Busan, Seoul, Daegu
2025-04-01
Recruiting
Daiichi Sankyo
Phase 3
510
Daegu, Goyang-si, Hwasun-gun, Incheon, Seongnam-si, Seoul
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
700
Bupyeong-gu, Busan, Cheongju-si, Daegu, Deagu, Eunpyeong-gu, Gangnam-gu, Goyang-si
2025-03-27
Recruiting
AstraZeneca
Phase 3
990
Anyang-si, Daegu, Iksan-si, Jeonju, Seoul, Uijeongbu-si, Wŏnju
2025-03-18
Active, closed
Amgen
Phase 3
1,105
Ansan-si, Gyeonggi-do, Daegu, Seongnam-si, Gyeonggi-do, Seoul, Wonju-si, Gangwon-do
2025-03-17
Recruiting
Hoffmann-La Roche
Phase 3
600
Busan, Daegu, Daejeon, Gangwon-do, Guri-si, Seoul
2025-03-17
Active, closed
Hoffmann-La Roche
Phase 4
274
Busan, Daegu, Seongnam-si, Seoul
2025-03-14
Recruiting
AstraZeneca
Phase 3
11,300
Bucheon-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon, Wŏnju, Yangsan
2025-03-14
Active, closed
Amgen
Phase 3
3,853
Ansan-si, Gyeonggi-do, Anyang-si, Gyeonggi-do, Bucheon, Gyeonggi-do, Busan, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Incheon
2025-03-12
Recruiting
AstraZeneca
Phase 3
840
Daegu, Goyang-si, Gyeonggi-do, Jeonnam, Seoul
2025-03-01
Recruiting
Daiichi Sankyo
Phase 3
726
Cheongju-si, Daegu, Goyang-si, Hwasun-gun, Incheon, Jeonju, Seongnam, Seongnam-si
2025-02-27
Recruiting
Takeda
Phase 3
171
Seongnam-si, Daegu, Seoul
2025-02-27
By invitation
Kyungpook National University Chilgok Hospital
Not applicable
246
Daegu
2025-02-26
Active, closed
Amgen
Phase 2
252
Cheongju Chungbuk, Daegu, Hwasun-gun, Jeollanam-do, Seongnam-si, Gyeonggi-do, Seoul
2025-02-26
Recruiting
Prevail Global Study
NCT06535854Coronary Artery Disease
Medtronic Vascular
Not applicable
1,205
Daegu, Seoul
2025-02-24
Recruiting
Dianthus Therapeutics
Phase 3
256
Daegu, Daejeon, Seoul, Uijeongbu-si, Yangsan
2025-02-10
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Daegu, Seoul
2025-02-01
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Hwasun-gun, Busan, Daegu, Seongnam, Seoul
2025-01-29
Recruiting
Takeda
Phase 3
70
Daegu, Seoul
2025-01-22
Recruiting
IRIS-Coroflex NEO Cohort
NCT06177743Coronary Artery Stenosis, Coronary Artery Disease
Seung-Jung Park
Observational
1,000
Seoul, Bucheon-si, Daegu, Gwangju, Ilsan, Sejong, Suwon, Uijeongbu-si
2025-01-09
Recruiting
Takeda
Phase 3
396
Busan, Daegu, Daejeon, Seoul, Suwon
2025-01-02
Recruiting
Duk-Woo Park, MD
Phase 4
1,040
Bucheon-si, Changwon, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Incheon
2024-12-18
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
1,714
Busan, Daegu, Gwangju, Ansan-si, Anyang-si, Bucheon-si, Hwaseong-si, Seongnam-si
2024-12-18
Active, closed
GlaxoSmithKline
Phase 1/2
14
Daegu, Gyeonggi-do, Seoul
2024-12-13
Active, closed
Safety Study of TPX-121 on Nasolabial Folds
NCT06533540Nasolabial Fold, Hypoplastic
Tego Science, Inc.
Phase 1
18
Daegu
2024-12-11
Recruiting
Yonsei University
Phase 2
40
Daegu, Daejeon, Hwasun, Jeju City, Pusan, Seoul
2024-12-11
Recruiting
Basilea Pharmaceutica
Phase 3
450
Daegu, Seoul, Suwon
2024-12-11
Recruiting
PepGen Inc
Phase 2
24
Pusan, Daegu, Seoul
2024-12-10
Active, closed
Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes
NCT06712615Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus
DrugPG-102
ProGen. Co., Ltd.
Phase 2
144
Bucheon-si, Daegu, Daejeon, Seongnam, Seoul
2024-12-05
Active, closed
Genmab
Phase 3
191
Suwon, Cheongju-si, Daegu, Goyang-si, Seoul
2024-11-25
Recruiting
Kyu Chang Won
Not applicable
5,950
Daegu, Seoul
2024-11-21
Active, closed
Daiichi Sankyo
Phase 3
700
Busan, Daegu, Hwasun-gun, Incheon, Jeonju, Seongnam-si, Seoul, Suwon
2024-11-19
Recruiting
PULSED AF Post-Approval Study
NCT06578104Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
580
Daegu, Seoul
2024-11-04
By invitation
Pusan National University Hospital
Not applicable
200
Busan, Daegu, Daejeon
2024-11-01
Active, closed
Il-Yang Pharm. Co., Ltd.
Observational
169
Anyang-si, Daegu
2024-10-24
Recruiting
Pfizer
Phase 3
900
Hwasun, Goyang-si, Seoul, Daegu, Junggu
2024-10-22
Active, closed
Pfizer
Phase 3
609
Hwasun, Goyang-si, Seoul, Daegu
2024-10-21
Recruiting
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
NCT06618638ADPKD (autosomal Dominant Polycystic Kidney Disease)
Seoul National University Hospital
Not applicable
340
Anyang-si, Seoul, Busan, Daegu, Gwangju
2024-10-21
Recruiting
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
NCT06257394Acute Lymphoblastic Leukemia, Pediatric
Hyoung Jin Kang
Phase 2
74
Daegu, Daejeon, Hwasun, Jeju City, Seoul, Yangsan
2024-10-20
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc
Phase 3
2,150
Nam-Gu, Daegu, Wŏnju, Incheon, Goyang-si, Seoul
2024-10-04
Recruiting
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
NCT06649240Ischemic Stroke, Small Vessel Cerebrovascular Disease, Cholesterol, LDL, Secondary Prevention
Seoul National University Hospital
Not applicable
4,016
Ansan, Anyang, Busan, Changwon, Cheongju-si, Chuncheon, Daegu, Daejeon
2024-10-04
Recruiting
GlaxoSmithKline
Phase 2
350
Ansan, Bucheon-si, Daegu, Seoul, Suwon Gyeonggi-do
2024-09-27
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Cheongju-si, Seongnam-si, Incheon, Seoul, Busan, Daegu, Gyeonggi-do, Ulsan
2024-09-27
Active, closed
argenx
Phase 3
141
Daegu, Seoul
2024-09-18
Active, closed
Dianthus Therapeutics
Phase 2
46
Daegu, Seoul
2024-09-17
Recruiting
AbbVie
Phase 2
590
Busan, Daejeon, Seoul, Daegu
2024-09-04
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Anyang, Cheonan, Daegu, Daejeon, Gangwon-do, Goyang-si, Seongnam-si, Seoul
2024-08-30
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Ansan-si, Busan, Cheonan-si, Cheongju-si, Daegu, Deagu, Goyang-si, Guri-si
2024-08-30
Active, closed
Ferring Pharmaceuticals
Observational
1,526
Busan, Daegu, Seongnam-si, Seoul
2024-08-27
Recruiting
CHA University
Phase 4
490
Seongnam-si, Daegu, Iksan, Ilsan, Seongnam, Seoul, Wŏnju
2024-08-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Wŏnju, Gwangju, Seongnam, Suwon, Cheongju-si, Busan, Haeundae-gu, Daegu
2024-08-05
Active, closed
BioNTech SE
Phase 2
110
Cheongju-si, Daegu, Goyang-si, Incheon, Jinju, Seoul, Suwon
2024-08-05
Active, closed
GlaxoSmithKline
Phase 3
10,212
Seoul, Ansan, Bucheon-si Kyunggi-do 14584, Daegu, Incheon, Jeonju, Kangwon-do, Suwon Gyeonggi-do
2024-08-01
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Daegu, Gwangju, Seoul
2024-07-31
Recruiting
AstraZeneca
Phase 2
80
Busan, Daegu, Gyeongsangnam-do, Incheon, Jeonju, Seogu, Seoul, Suwon
2024-07-16
Recruiting
AO Innovation Translation Center
Observational
600
Daegu
2024-07-03
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Daegu, Gwangju, Seoul
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bucheon-si, Goyang-si, Seongnam-si, Suwon, Yangsan, Busan, Cheongju-si, Daegu
2024-06-25
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Deagu, Gwangju, Incheon
2024-06-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Wŏnju, Ansan-si, Suwon, Busan, Haeundae-gu, Dongjak-gu, Daegu, Daejeon
2024-06-05
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Busan, Daegu, Seoul
2024-06-03
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Hoffmann-La Roche
Phase 3
1,800
Bucheon-si, Busan, Daegu, Incheon, Seoul
2024-05-24
Recruiting
Daiichi Sankyo
Phase 3
540
Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon
2024-05-21
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC), HPV Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)
Inhibrx Biosciences, Inc
Phase 2/3
450
Seoul, Yangsan, Daegu
2024-05-14
Active, closed
Sanofi
Phase 3
1,541
Daegu, Gwangju, Ansan-si, Seongnam-si, Suwon, Yangsan, Bupyeong-gu, Seoul
2024-05-08
Recruiting
CSL Behring
Phase 2/3
3,110
Ilsan-gu, Anyang-si, Daegu, Gangnam-gu, Goyang-si, Guri-si, Gwangju, Seoul
2024-04-27
Recruiting
Seung-Jung Park
Not applicable
960
Seoul, Ansan, Anyang, Bucheon-si, Busan, Changwon, Chuncheon, Daegu
2024-04-25
Recruiting
CMG Pharmaceutical Co. Ltd
Phase 3
240
Anyang, Buchon, Busan, Cheonan, Daegu, Daejeon, Goyang-si, Guri-si
2024-04-19
Active, closed
GlaxoSmithKline
Phase 4
1,358
Busan, Daegu, Seongnam-si Gyeonggi-do, Seoul, Suwon Kyunggi-do
2024-04-16
Recruiting
AstraZeneca
Phase 3
3,850
Anyang-si, Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gwangmyeong
2024-04-12
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Chungcheongbuk Do, Daegu, Gyeonggi-do, Jeollanam-do, Seoul, Yangsan
2024-04-09
Recruiting
Ho Joon Im
Phase 2
90
Daegu, Daejeon, Hwasun, Jeju City, Seoul, Yangsan
2024-04-04
Active, closed
Gilead Sciences
Phase 2
228
Busan, Daegu, Daejeon, Guri-si, Jongno-Gu, Nam-Gu, Seongdong-gu, Seoul
2024-03-27
Recruiting
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
NCT06163430Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
330
Uijeongbu-si, Anyang-si, Busan, Daegu
2024-03-26
Recruiting
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
NCT06227754ST Elevation Myocardial Infarction, Myocardial Infarction
Chonnam National University Hospital
Not applicable
1,500
Daegu, Gwangju, Iksan, Incheon, Jeju City, Jeonju, Jinju, Seoul
2024-03-25
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Hoffmann-La Roche
Phase 3
1,350
Busan, Daegu, Gyeonggi-do, Incheon, Seoul
2024-03-13
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Busan, Daegu, Seoul
2024-03-13
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,942
Busan, Daegu, Donggu, Goyang, Seoul, Uijeongbu-si, Ulsan
2024-03-13
Recruiting
Eli Lilly and Company
Phase 3
90
Busan, Daegu, Seoul
2024-03-13
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bucheon-si, Daegu, Daejeon, Dongjak-gu, Gwangju, Namdong-gu, Seongnam, Seoul
2024-03-05
Recruiting
Hee Young Ju
Phase 2
116
Seoul, Yangsan, Daegu, Daejeon, Hwasun, Jeju City, Seongnam, Suwon
2024-03-05
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
Daiichi Sankyo
Phase 2
740
Daegu, Gyeonggi-do, Seongnam, Seoul
2024-02-26
Recruiting
AstraZeneca
Phase 3
5,250
Anyang-si, Busan, Daegu, Gwangju, Jeonju, Seoul, Uijeongbu-si, Ulsan
2024-02-21
Active, closed
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
NCT05995600Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack, Cerebrovascular Disease
Seoul National University Hospital
Phase 4
200
Anyang, Busan, Cheongju-si, Chuncheon, Daegu, Daejeon, Guri-si, Gwangju
2024-02-20
Active, closed
Regeneron Pharmaceuticals
Phase 3
216
Gyeonggi-do, Suwon, Yangsan, Jeonju, Incheon, Busan, Daegu, Seoul
2024-02-15
Recruiting
Vividion Therapeutics, Inc.
Phase 1
280
Daegu, Gyeonggi-do, Seongnam-si, Seoul
2024-01-25
Active, closed
Samsung Bioepis Co., Ltd.
Phase 1
163
Ansan, Busan, Daegu, Hwasun, Incheon, Jinju, Seongnam, Seoul
2024-01-16
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
AVEO Pharmaceuticals, Inc.
Phase 3
410
Daegu, Seoul, Suwon
2024-01-11
Active, closed
Kyowa Kirin Co., Ltd.
Phase 2
185
Daegu, Busan, Seongam, Seongnam-si, Incheon, Seoul
2024-01-09
Recruiting
Daiichi Sankyo
Phase 3
75
Daegu, Goyang-si, Seoul
2024-01-05
Recruiting
The Treatment Effect for Asymptomatic Common Bile Duct Stone
NCT06215040Choledocholithiasis, Asymptomatic Condition, Quality of Life
Kyungpook National University Hospital
Observational
120
Daegu
2024-01-02
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Suwon, Jeonju, Incheon, Busan, Daegu, Seoul, Ulsan
2023-12-28
Recruiting
Double Unit Cord Blood Transplant in Hematologic Malignancies.
NCT06712108Adult Double Unit Cord Blood Transplant
Seoul National University Hospital
Observational
40
Jeonju, Daegu, Pusan, Seongnam, Seoul
2023-12-21
Recruiting
Eli Lilly and Company
Phase 3
1,264
Cheongju-si, Daegu, Deagu, Gangnam-gu, Goyang-si, Hwasun, Seoul, Suwon
2023-12-21
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Seongnam-si, Jinju, Hwasun, Busan, Daegu, Incheon, Seoul
2023-12-20
Recruiting
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
NCT05979545Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection, Carbapenem-Resistant Enterobacteriaceae Infection
National University of Singapore
Phase 4
1,526
Ansan, Cheonan, Daegu, Seongnam
2023-12-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Goyang-si, Seongnam, Suwon, Cheongju-si, Daegu, Seoul
2023-12-06
Active, closed
Gilead Sciences
Phase 2
176
Seodaemun-Gu, Busan, Daegu, Junggu, Seoul
2023-12-05
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2023-12-01
Active, closed
Cellid Co., Ltd.
Phase 3
4,000
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seoul
2023-11-27
Active, closed
AstraZeneca
Phase 3
1,835
Ansan-si, Busan, Cheonan-si, Daegu, Goyang-si, Seoul
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 2
227
Pusan, Daejeon, Gwangju, Seongnam, Junggu, Seoul, Daegu
2023-11-07
Recruiting
CeraFlex PFO Closure System PMCF Study
NCT06120270Patent Foramen Ovale
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
180
Gwangju, Daegu, Seoul, Suwon
2023-11-03
Recruiting
Astellas Pharma Korea, Inc.
Observational
228
Goyang-si, Suwon, Jeollanam-do, Jeonju, Busan, Daegu, Daejeon, Incheon
2023-11-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Wŏnju, Suwon, Busan, Haeundae-gu, Dongjak-gu, Daegu, Daejeon, Seoul
2023-10-25
Recruiting
AbbVie
Phase 3
1,500
Busan, Daegu, Daejeon, Seongnam-si, Incheon, Jeonju, Seoul
2023-10-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Seongnam, Suwon, Busan, Daegu, Seoul
2023-10-09
Active, closed
AstraZeneca
Phase 3
5,511
Cheonan-si, Daegu, Goyang-si, Seongnam-si, Seoul
2023-10-05
Active, closed
Acrotech Biopharma Inc.
Phase 3
504
Busan, Suwon, Daegu, Sinchon-dong, Songpa-dong, Incheon, Seoul
2023-10-04
Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
NCT06038578Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Toray Industries, Inc
Phase 2
146
Seongnam-si, Hwasun, Daegu, Seoul
2023-10-04
Recruiting
Samsung Medical Center
Not applicable
2,000
Bucheon-si, Chuncheon, Chungju, Daegu, Daejeon, Gwangju, Gwangmyeong, Ilsan
2023-10-02
Recruiting
AstraZeneca
Phase 3
800
Daegu, Goyang-si, Gyeonggi-do, Seoul
2023-09-22
Active, closed
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
NCT05846893Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Coronary Stenosis
B. Braun Medical Industries Sdn. Bhd.
Not applicable
1,436
Daegu, Chuncheon, Donggu, Ansan-si, Goyang-si, Changwon, Seoul
2023-09-07
Recruiting
Gilead Sciences
Phase 3
402
Busan, Daegu, Gwangju, Seongnam, Seoul
2023-09-07
Recruiting
Ipsen
Phase 3
276
Bucheon-si, Busan, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Incheon, Junggu
2023-08-31
Recruiting
GlaxoSmithKline
Phase 3
892
Daegu, Gyeonggi-do, Seoul
2023-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Daegu, Daejeon, Seoul
2023-07-19
Active, closed
AstraZeneca
Phase 2
60
Anyang-si, Busan, Daegu, Seoul
2023-07-18
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
Taiho Oncology, Inc.
Phase 2
120
Busan, Daegu, Jinju, Seongnam, Seoul
2023-07-05
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Bucheon-si, Daegu, Gyeonggi-do, Incheon, Jeollabuk-do, Seoul, Wŏnju
2023-06-28
Active, closed
OncoC4, Inc.
Phase 3
630
Cheongju-si, Daegu, Goyang-si, Seoul, Suwon
2023-06-28
Recruiting
Novartis Pharmaceuticals
Observational
44
Daegu, Suwon, Incheon, Seoul, Busan, Daejeon, Jeollanam
2023-06-12
Recruiting
Takeda
Phase 3
240
Daegu, Incheon, Seoul
2023-05-16
Recruiting
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
NCT06088121Alzheimer's Disease, Dementia, Brain Diseases, Central Nervous System Diseases
Advanced Technology & Communications
Not applicable
180
Incheon, Gwangmyeong, Jeonju, Gwangju, Daegu, Gyeonggi-do, Daejeon, Seoul
2023-05-15
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Anyang-si, Busan, Cheonan-si, Cheongju-si, Chuncheon, Daegu, Daejeon, Goyang-si
2023-04-11
Recruiting
Seoul National University Bundang Hospital
Observational
1,240
Daegu, Gyeonggi-do, Hwasun, Ilsan, Jinju, Seongnam-si, Seoul, Yangsan
2023-04-01
Recruiting
AstraZeneca
Phase 3
4,300
Busan, Daegu, Donggu, Goyang-si, Jeonnam, Seongbuk-Gu, Seoul
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Busan, Cheongju-si, Daegu, Gyeonggi-do, Jeollanam-do, Seoul
2023-03-23
Recruiting
Seoul National University Hospital
Phase 4
11,086
Seoul, Andong, Busan, Changwon, Cheonan, Cheongju-si, Chuncheon, Daegu
2023-03-22
Active, closed
AbbVie
Phase 3
520
Goyang-si, Seongnam, Seongnam-si, Daegu, Seoul
2023-03-15
By invitation
Seung-Whan Lee, M.D., Ph.D.
Phase 4
4,000
Bucheon-si, Changwon, Cheonju, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2023-03-14
Recruiting
Seung-Whan Lee, M.D., Ph.D.
Not applicable
2,400
Anyang, Bucheon-si, Busan, Changwon, Cheongju-si, Daegu, Gangneung, Iksan
2023-03-13
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Anyang-si, Busan, Daegu, Daejeon, Goyang-si, Gwangju, Incheon, Jeju Special
2023-02-15
Active, closed
Regeneron Pharmaceuticals
Phase 2
120
Seongnam-si, Busan, Daegu, Seoul
2023-02-09
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Wŏnju, Seongnam-si, Suwon, Daegu, Ansan-si, Busan, Daejeon, Incheon
2023-01-16
Active, closed
Daiichi Sankyo
Phase 3
1,233
Cheongju-si, Daegu, Gangnam-Gu, Goyang-si, Jinju-si Gyeongsangnam-do, Seongnam-si, Seoul
2023-01-11
Active, closed
Exelixis
Phase 3
317
Busan, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
2023-01-01
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
Pharvaris Netherlands B.V.
Phase 2/3
150
Daegu, Seoul
2022-12-28
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Anyang-si, Busan, Daegu, Daejeon, Goyang-si, Gwangju, Gyeonggi-do, Seongnam-si
2022-12-27
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Seongnam-si, Gwangju, Seoul, Chuncheon, Incheon, Cheonan, Daegu, Guri-si
2022-12-23
Recruiting
Seoul National University Hospital
Phase 3
236
Busan, Daegu, Goyang, Hwasun, Seongnam, Seoul, Suwon
2022-12-15
Recruiting
AstraZeneca
Phase 3
3,527
Daegu, Jeonju, Seoul
2022-12-13
Active, closed
Viatris Innovation GmbH
Phase 3
470
Busan, Daegu, Junggu, Seoul
2022-12-13
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Daegu, Hwaseong-si, Suwon, Incheon, Seoul, Gwangju
2022-12-09
Recruiting
Pfizer
Phase 3
100
Seoul, Daegu
2022-12-09
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
Hoffmann-La Roche
Observational
6,000
Seongnam-si, Daegu
2022-11-21
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Busan, Daegu, Gwangju, Seoul
2022-11-21
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2
87
Daegu, Seoul
2022-11-07
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Bucheon-si, Seongnam-si, Yangsan, Daegu, Daejeon, Incheon, Seongnam-si, Gyeonggi-do, Seoul
2022-11-01
Active, closed
Hoffmann-La Roche
Phase 3
68
Daegu, Gyeongsangnam-do, Jeollanam-do, Seongnam-si, Seoul
2022-11-01
Recruiting
Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
NCT05490433Breast Cancer Classified as TNM Stage 0-IIIa
Yonsei University
Not applicable
790
Changwon, Daegu, Goyang-si, Incheon, Pusan, Sejong, Seoul, Yongin-si
2022-10-26
Recruiting
Asan Medical Center
Phase 4
3,944
Bucheon-si, Busan, Changwon, Chuncheon, Chungju, Daegu, Daejeon, Gangneung
2022-10-21
Active, closed
Eli Lilly and Company
Phase 3
8,000
Busan, Cheonan-si, Cheongju-si, Daegu, Goyang-si, Gyeongsan-si, Hwasun-gun, Incheon
2022-10-04
By invitation
Comparison Study Between Suction Aspiration and Combination Technique in Acute Cerebral Infarction
NCT06254755Acute Cerebral Ischemia Requiring for Mechanical Thrombectomy
Inje University Haeundae Paik Hospital
Not applicable
1,132
Goyang-si, Seongnam-si, Changwon, Bucheon-si, Daegu, Daejeon, Incheon, Pohang
2022-10-01
Active, closed
Seoul National University Bundang Hospital
Observational
1,000
Bucheon-si, Chungju, Daegu, Daejeon, Goyang, Hwasun, Incheon, Jeonju
2022-09-28
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
Janssen-Cilag Ltd.
Phase 3
288
Busan, Daegu, Gyeonggi-do, Seoul
2022-09-27
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Busan, Daegu, Gwangju, Gyeonggi-do, Hwaseong-si, Seoul, Suwon, Wŏnju
2022-09-19
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Busan, Daegu, Goyang-si, Gwangju, Gyeonggi-do, Seoul, Suwon
2022-09-13
Recruiting
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
NCT05044273Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases, Myocardial Ischemia
Jung-min Ahn
Observational
2,000
Anyang, Busan, Changwon, Daegu, Gangneung, Gwangju, Iksan, Seongnam
2022-09-01
Active, closed
Yonsei University
Observational
260
Busan, Chuncheon, Ansan-si, Goyang-si, Yongin-si, Daegu, Yangsan, Jeonju
2022-08-31
Recruiting
Qurient Co., Ltd.
Phase 1/2
130
Daegu, Goyang-si, Seongnam-si, Seoul, Suwon
2022-08-30
Active, closed
Sanofi
Phase 2/3
1,856
Daegu, Gwangju, Ansan-si, Seongnam-si, Suwon, Yangsan, Bupyeong-Gu, Seoul
2022-08-22
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 1
220
Daegu, Goyang-si, Seongnam, Seoul
2022-08-04
Active, closed
Drug-Coated Balloon in Patients With High Bleeding Risk
NCT05221931Coronary Artery Disease
Samsung Medical Center
Not applicable
1,359
Ansan, Cheongju-si, Daegu, Gangneung, Gwangju, Gwangmyeong, Incheon, Jinju
2022-07-29
Recruiting
Addpharma Inc.
Phase 3
520
Daegu
2022-07-27
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Busan, Daegu, Goyang-si, Gwangju, Hwaseong-si, Seongnam-si, Seoul, Suwon
2022-07-22
Active, closed
PureTech
Phase 2
240
Bucheon-si, Goyang-si, Busan, Daegu, Gwangju, Gyeonggi-do, Incheon, Seoul
2022-07-22
Active, closed
Incyte Corporation
Phase 1/2
53
Suwon, Busan, Daegu, Incheon, Jeonju, Seoul, Ulsan
2022-07-19
Recruiting
Novartis Pharmaceuticals
Observational
900
Cheonan Si, Daegu, Goyang-si, Suwon, Gyeonggi-do, Seoul, Busan, Daejeon
2022-06-29
Recruiting
Adagene Inc
Phase 1/2
186
Seogu, Seongnam, Suwon, Cheongju-si, Seoul, Daegu
2022-06-15
Active, closed
Yuhan Corporation
Observational
1,219
Busan, Daegu, Gwangju, Seoul
2022-06-08
Recruiting
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
NCT05304377Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Cml
Enliven Therapeutics
Phase 1
250
Jeonju, Daegu, Gyeonggi-do, Hwasun, Seoul
2022-05-22
Active, closed
Novartis Pharmaceuticals
Observational
683
Daegu, Wŏnju, Bucheon-si, Bundang Gu, Goyang-si, Yangsan, Jeonju, Suncheon
2022-05-09
Active, closed
Novartis Pharmaceuticals
Observational
670
Daegu, Kangwon Do, Wŏnju, Goyang-si, Guri-si, Jinju, Jeonju, Iksan Si
2022-05-09
Recruiting
SK Life Science, Inc.
Phase 3
252
Daegu, Seoul
2022-04-28
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Busan, Daegu, Gwangju, Seoul, Anyang, Hwaseong-si, Seongnam
2022-04-05
Active, closed
AstraZeneca
Phase 3
760
Busan, Daegu, Goyang-si, Junggu, Seoul
2022-03-28
Active, closed
Pfizer
Phase 3
854
Namdong-gu, Hwasun Gun, Seongnam, Busan, Seoul, Daegu, Junggu
2022-03-25
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Busan, Daegu, Gwangju, Goyang-si, Anyang, Hwasŏng, Seongnam, Seoul
2022-03-15
Active, closed
Eli Lilly and Company
Phase 3
368
Seongnam, Seoul, Daegu
2022-03-11
Active, closed
Daiichi Sankyo
Phase 3
740
Seongnam-si, Jinju, Cheongju-si, Daegu, Goyang-si, Seoul, Songpa-gu
2022-03-04
Active, closed
AstraZeneca
Phase 3
390
Daegu, Jinju, Seoul, Suwon
2022-02-21
Recruiting
Joon Bum Kim
Phase 4
1,300
Bucheon-si, Busan, Daegu, Gangneung, Gwangju, Seongnam, Seoul, Suwon
2022-02-21
Active, closed
AstraZeneca
Phase 3
791
Daegu, Goyang-si, Incheon, Jinju, Seoul, Suwon
2022-02-18
Recruiting
Takeda
Phase 3
120
Daegu, Incheon, Seongnam, Seoul
2022-02-10
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Busan, Daegu, Daejeon, Dongdaemun-gu, Goyang-si, Gwangju, Gyeonggi-do, Seoul
2022-01-19
Active, closed
Sanofi
Phase 4
1,339
Busan, Wŏnju, Daegu, Bupyeong-Gu, Seoul
2021-12-16
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Daegu, Seoul
2021-12-14
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Anyang-si, Busan, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2021-12-02
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Daegu, Wŏnju, Bundang Gu, Jinju, Yangsan, Seoul, Cheongju-si, Busan
2021-11-23
Active, closed
Hoffmann-La Roche
Phase 3
660
Cheongju-si, Daegu, Gyeongsangnam-do, Seongnam-si, Seoul, Ulsan
2021-11-18
Recruiting
Pfizer
Phase 3
245
Seoul, Daegu
2021-11-17
Active, closed
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
NCT04829604HER2 Positive Metastatic Breast Cancer
DrugARX788
Ambrx, Inc.
Phase 2
72
Daegu, Seongnam-si, Seoul
2021-10-26
Recruiting
Pfizer
Phase 3
893
Seongnam-si, Hwasun-gun, Busan, Seoul, Daegu, Incheon
2021-10-04
Active, closed
Eli Lilly and Company
Phase 3
874
Cheonan-si, Namdong-gu, Suwon, Daegu, Busan, Seoul
2021-10-04
Active, closed
Asan Medical Center
Phase 4
600
Daegu, Seoul, Ulsan
2021-08-23
Active, closed
Merck Sharp & Dohme LLC
Phase 2
730
Hwasun Gun, Daegu, Seoul
2021-08-18
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gangseo-gu, Goyang-si, Incheon
2021-08-14
By invitation
BioCryst Pharmaceuticals
Phase 3
139
Daegu, Gwangju, Seoul
2021-07-23
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Busan, Daegu, Seoul
2021-07-15
Active, closed
Hoffmann-La Roche
Phase 3
451
Busan, Daegu, Incheon, Seongnam-si, Seoul
2021-07-14
Active, closed
AstraZeneca
Phase 3
315
Cheonan-si, Daegu, Goyang-si, Seongnam-si, Seoul
2021-06-30
Active, closed
MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients
NCT04651634Head and Neck Squamous Cell Carcinoma, Oral Mucositis
DrugCCRT
MitoImmune Therapeutics
Phase 2
60
Suwon, Jeonju, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Incheon, Seoul
2021-06-21
By invitation
Philips Clinical & Medical Affairs Global
Not applicable
3,212
Bucheon-si, Daegu, Seoul
2021-06-17
Active, closed
Nature Cell Co. Ltd.
Phase 2/3
173
Daegu, Seoul
2021-05-26
Active, closed
Daiichi Sankyo
Phase 3
490
Daegu, Hwasun, Seongnam, Seoul
2021-05-21
Recruiting
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
NCT04416581Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Myocardial Infarction
Duk-Woo Park, MD
Phase 4
3,320
Anyang, Bucheon-si, Busan, Changwon, Cheonan, Cheonju, Chuncheon, Daegu
2021-05-12
Active, closed
Pfizer
Phase 3
599
Goyang-si, Hwasun-gun, Seongnam, Daegu, Seoul
2021-05-12
Active, closed
Incyte Corporation
Phase 3
899
Busan, Daegu, Goyang-si, Incheon, Jeonju, Jinju, Seoul, Yangsan
2021-05-11
Active, closed
ALX Oncology Inc.
Phase 2
172
Cheongju-si, Daegu, Incheon, Seongnam, Seongnam-si, Seoul
2021-05-10
Active, closed
AstraZeneca
Phase 3
1,157
Cheonan-si, Daegu, Goyang-si, Seoul
2021-04-26
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
Novartis Pharmaceuticals
Phase 3
430
Jinju, Busan, Daegu, Gyeonggi-do, Incheon, Jeonju, Seoul, Ulsan
2021-04-09
Active, closed
ALX Oncology Inc.
Phase 2
189
Cheongju-si, Daegu, Daejeon, Gyeonggi-do, Incheon, Seongnam, Seoul, Suwon
2021-04-02
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Daegu, Gangwon-do, Gyeonggi-do, Seoul
2021-04-01
Active, closed
Hoffmann-La Roche
Phase 3
751
Daegu, Goyang-si, Seoul
2021-03-24
Active, closed
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
NCT04938583Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV
CanariaBio Inc.
Phase 1/2
54
Seoul, Daegu, Seongnam-si
2021-03-17
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Busan, Seongnam-si, Hwasun, Daegu, Seoul
2021-03-11
Active, closed
Celgene
Phase 3
313
Daegu, Hwasun-Gun, Seongnam-si, Seoul
2021-02-25
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
Daegu, Seoul
2021-02-23
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Busan, Cheongju-si, Daegu, Hwasun-gun, Incheon, Junggu, Seongnam-si, Seoul
2021-02-23
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Daiichi Sankyo
Phase 2
277
Songpa-gu, Cheongju-si, Daegu, Goyang-si, Seongnam, Seoul
2021-02-02
Active, closed
Genmab
Phase 3
483
Busan, Daegu, Geumam, Seoul, Ulsan
2021-01-13
Active, closed
Daiichi Sankyo
Phase 3
605
Cheongju-si, Daegu, Gyeonggi-do, Seongnam-si, Seoul
2020-12-21
Active, closed
Pfizer
Phase 3
841
Goyang-si, Busan, Daegu, Incheon, Seoul
2020-12-21
Active, closed
AstraZeneca
Phase 3
358
Daegu, Hwasun-gun, Incheon, Seoul, Yangsan
2020-12-16
Active, closed
GlaxoSmithKline
Phase 2/3
758
Cheongju Chungcheongbuk-do, Daegu, Gyeonggi-do, Pusan, Seongnam-si Gyeonggi-do, Seoul, Suwon Kyunggi-do
2020-12-08
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Busan, Daegu, Gangnam Gu, Goyang-si, Hwasun-gun, Namdong, Seoul, Yangsan
2020-12-07
Active, closed
Daiichi Sankyo
Phase 3
1,600
Daegu, Gyeonggi-do, Incheon, Irwon-dong, Seoul, Songpa-gu, Yongsan
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Busan, Cheongju-si, Daegu, Goyang-si, Junggu, Seoul, Suwon
2020-12-02
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer
Phase 2
320
Seongnam-si, Seoul, Daegu
2020-11-16
Active, closed
Kyungpook National University Hospital
Phase 2
364
Daegu, Daejeon, Gwangju, Incheon, Jeonju, Seoul
2020-10-23
Active, closed
Kyungpook National University Hospital
Phase 3
708
Hwasun, Daegu, Seoul, Suwon
2020-10-23
Active, closed
Bayer
Phase 3
774
Chungcheongbuk-do, Daegu, Gwangju, Incheon, Seoul
2020-10-20
Active, closed
Exelixis
Phase 3
575
Junggu, Goyang-si, Seongnam-si, Hwasun, Busan, Daegu, Gwangju, Seoul
2020-10-19
Active, closed
AstraZeneca
Phase 3
640
Daegu, Seoul, Suwon
2020-10-19
Active, closed
Hoffmann-La Roche
Phase 3
992
Cheongju-si, Daegu, Gyeonggi-do, Incheon, Seoul, Ulsan
2020-10-09
Recruiting
Duk-Woo Park, MD
Observational
2,000
Chuncheon, Daegu, Daejeon, Gangneung, Kwangju, Pusan, Seoul, Suncheon
2020-09-17
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 2
70
Daegu, Gyeonggi-do, Hwasun, Incheon, Seoul, Suwon
2020-09-10
Active, closed
PharmaEssentia
Phase 3
174
Daegu, Incheon, Seoul
2020-08-25
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
240
Goyang-si, Suwon, Jeonju, Busan, Daegu, Incheon, Seoul
2020-08-20
Active, closed
AstraZeneca
Phase 3
866
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2020-07-24
Active, closed
AstraZeneca
Phase 3
1,012
Daegu, Goyang-si, Seongnam-si, Seoul
2020-07-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Goyang-si, Seongnam-si, Suwon, Jinju, Cheongju-si, Daegu, Seoul
2020-07-06
Active, closed
AstraZeneca
Phase 3
818
Busan, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul, Suwon
2020-04-16
Active, closed
R-Bio
Phase 3
129
Daegu, Seoul
2020-04-13
Active, closed
Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery
NCT04585074Breast Neoplasms, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Benign Breast Disease
Severance Hospital
Observational
2,000
Busan, Sejong, Daegu, Wŏnju, Ansan, Goyang-si, Yongin-si, Changwon
2020-04-08
Active, closed
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
NCT04152499Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma
Klus Pharma Inc.
Phase 1/2
1,410
Seongnam-si, Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Seoul
2020-02-28
Recruiting
Asan Medical Center
Observational
3,000
Bucheon-si, Busan, Changwon, Chuncheon, Daegu, Daejeon, Gangneung, Jeonju
2020-02-20
Recruiting
National Cancer Center, Korea
Phase 3
1,700
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul
2020-02-15
Active, closed
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)
NCT04626882Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis
Chonnam National University Hospital
Not applicable
994
Bucheon-si, Changwon, Daegu, Gangneung, Gwangju, Jeonju, Jinju, Seoul
2019-12-30
Active, closed
Pfizer
Phase 3
1,068
Goyang-si, Seongnam-si, Seoul, Daegu
2019-12-30
Active, closed
Seung-Jung Park
Observational
2,000
Busan, Chuncheon, Daegu, Gangneung, Seoul, Suncheon, Wŏnju
2019-12-23
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Bucheon-si, Daegu, Seongnam, Seoul
2019-10-03
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Busan, Daegu, Gyeonggi-do, Incheon, Seongnam-si, Seoul, Suwon
2019-09-26
Active, closed
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT04095364Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8
NRG Oncology
Phase 3
450
Goyang-si, Seoul, Seongnam, Daegu, Incheon
2019-09-20
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
Novartis Pharmaceuticals
Phase 1/2
300
Daegu, Goyang-si, Incheon, Seoul
2019-09-18
Active, closed
Pfizer
Phase 3
896
Wŏnju, Suwon, Daegu, Busan
2019-09-05
Active, closed
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
NCT03914612Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma
National Cancer Institute (NCI)
Phase 3
813
Dalseo-gu, Seoul, Seongnam, Daegu
2019-08-22
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Daegu, Daejeon, Seoul
2019-08-15
Active, closed
Biogen
Observational
74
Busan, Changwon, Cheongju-si, Daegu, Daejeon, Gwangju, Jeonju, Seoul
2019-07-02
Active, closed
AstraZeneca
Phase 3
923
Busan, Cheonan-si, Cheongju-si, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2019-06-25
Active, closed
SCM Lifescience Co., LTD.
Observational
42
Bucheon-si, Daegu, Goyang-si, Gwangju, Incheon, Suwon
2019-05-10
Recruiting
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
NCT03929887Glomerular Disease, Minimal Change Disease, IgA Nephropathy, Membranous Nephropathy
Seoul National University Hospital
Observational
3,000
Chuncheon, Daegu, Seoul
2019-05-01
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 2
393
Seongnam-si, Suwon, Daegu, Gyeonggi-do, Seoul
2019-03-15
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Seoul, Daegu, Pusan, Seongnam
2019-03-11
Active, closed
Young-Suk Lim
Phase 4
780
Daegu, Seongnam, Seoul, Ulsan
2019-02-18
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Seongnam-si, Seoul
2019-01-25
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
507
Daegu, Goyang-si, Gyeonggi-do, Incheon, Jeollanam-do, Jeonju, Seongnam-si, Seoul
2018-11-28
Active, closed
AstraZeneca
Phase 3
407
Daegu, Gwangju, Seoul
2018-11-27
Active, closed
AstraZeneca
Phase 3
1,063
Daegu, Goyang-si, Gyeonggi-do, Incheon, Seoul
2018-11-16
Active, closed
AstraZeneca
Phase 3
895
Daegu, Goyang-si, Seoul
2018-10-31
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Daegu, Seoul
2018-10-29
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Takeda
Phase 3
245
Suwon, Daegu, Jeonju, Busan
2018-10-04
Active, closed
AstraZeneca
Phase 3
730
Changwon-si, Cheongju-si, Daegu, Goyang-si, Jinju, Seongnam-si, Seoul, Suwon
2018-09-27
Recruiting
Novartis Pharmaceuticals
Observational
700
Daegu, Seongnam-si, Seoul, Yangsan, Yongin-si
2018-09-25
Recruiting
Seung-Jung Park
Observational
500
Bucheon-si, Daegu, Daejeon, Gwangju, Pusan, Seongnam, Seoul
2018-09-04
Active, closed
AbbVie
Phase 3
1,242
Busan, Daejeon, Guri-si, Seongnam, Suwon, Seoul, Daegu
2018-08-28
Active, closed
Gilead Sciences
Phase 2
502
Daegu, Goyang-si, Gwangju, Hwasun, Seongbuk-Gu, Seoul, Suwon, Wŏnju
2018-08-13
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
Genmab
Phase 1/2
666
Busan, Daegu, Goyang-si, Jeonju, Seongnam-si, Seoul
2018-06-26
Rows per page Showing 1–500 of 553
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/daegu

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,409 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 553 of those studies with a site in Daegu.

How many clinical trials are recruiting in Daegu?

274 of the 553 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 17 have not yet opened recruitment, 247 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Daegu), 553 studies
PhaseStudiesRecruitingShare
Phase 330713355.5%
Phase 2774213.9%
Observational55369.9%
Not applicable48298.7%
Phase 425164.5%
Phase 2/321103.8%
Phase 1/21362.4%
Phase 1721.3%

Most active sponsors

Lead sponsors with the most studies (Daegu)
Lead sponsorStudiesRecruiting
AstraZeneca6128
Hoffmann-La Roche2512
Janssen Research & Development, LLC246
Merck Sharp & Dohme LLC199
Pfizer169
Daiichi Sankyo158
Eli Lilly and Company1510
AbbVie144
GlaxoSmithKline147
Novartis Pharmaceuticals125
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.